103 related articles for article (PubMed ID: 16585579)
1. SUMOylation interferes with CCAAT/enhancer-binding protein beta-mediated c-myc repression, but not IL-4 activation in T cells.
Berberich-Siebelt F; Berberich I; Andrulis M; Santner-Nanan B; Jha MK; Klein-Hessling S; Schimpl A; Serfling E
J Immunol; 2006 Apr; 176(8):4843-51. PubMed ID: 16585579
[TBL] [Abstract][Full Text] [Related]
2. CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals.
Rosati M; Valentin A; Patenaude DJ; Pavlakis GN
J Immunol; 2001 Aug; 167(3):1654-62. PubMed ID: 11466389
[TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
[TBL] [Abstract][Full Text] [Related]
4. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
5. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
[TBL] [Abstract][Full Text] [Related]
6. Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein beta and delta in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages.
Liu YW; Tseng HP; Chen LC; Chen BK; Chang WC
J Immunol; 2003 Jul; 171(2):821-8. PubMed ID: 12847250
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Id2 expression by CCAAT/enhancer binding protein beta.
Karaya K; Mori S; Kimoto H; Shima Y; Tsuji Y; Kurooka H; Akira S; Yokota Y
Nucleic Acids Res; 2005; 33(6):1924-34. PubMed ID: 15809228
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
9. Identification of new sites of binding and activation of the murine alpha1(I) collagen promoter by CCAAT/enhancer binding protein beta.
Attard FA; Wang L; Potter JJ; Rennie-Tankersley L; Mezey E
DNA Cell Biol; 2001 Aug; 20(8):455-63. PubMed ID: 11560777
[TBL] [Abstract][Full Text] [Related]
10. Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 activation: the role in glutathione S-transferase A2 gene repression.
Park IN; Cho IJ; Kim SG
Drug Metab Dispos; 2004 Sep; 32(9):893-7. PubMed ID: 15319326
[TBL] [Abstract][Full Text] [Related]
11. Effect of phosphorylation and S-S bond-induced dimerization on DNA binding and transcriptional activation by C/EBPbeta.
Kim JW; Tang QQ; Li X; Lane MD
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1800-4. PubMed ID: 17264204
[TBL] [Abstract][Full Text] [Related]
12. A positive regulatory domain in CCAAT/enhancer binding protein β (C/EBPΒ) is required for the glucocorticoid-mediated displacement of histone deacetylase 1 (HDAC1) from the C/ebpα promoter and maximum adipogenesis.
Abdou HS; Atlas E; Haché RJ
Endocrinology; 2013 Apr; 154(4):1454-64. PubMed ID: 23456364
[TBL] [Abstract][Full Text] [Related]
13. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.
Dhawan P; Peng X; Sutton AL; MacDonald PN; Croniger CM; Trautwein C; Centrella M; McCarthy TL; Christakos S
Mol Cell Biol; 2005 Jan; 25(1):472-87. PubMed ID: 15601867
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E(2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPbeta and cyclic adenosine 5'-monophosphate response element binding protein.
Dumais N; Bounou S; Olivier M; Tremblay MJ
J Immunol; 2002 Jan; 168(1):274-82. PubMed ID: 11751971
[TBL] [Abstract][Full Text] [Related]
15. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells.
Christian M; Pohnke Y; Kempf R; Gellersen B; Brosens JJ
Mol Endocrinol; 2002 Jan; 16(1):141-54. PubMed ID: 11773445
[TBL] [Abstract][Full Text] [Related]
16. C/EBPbeta interacts with the P-enolpyruvate carboxykinase adipocyte-specific enhancer.
Eubank DW; Williams SC; Beale EG
Biochem Biophys Res Commun; 2001 Jul; 285(3):811-9. PubMed ID: 11453665
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4.
Tominaga H; Maeda S; Hayashi M; Takeda S; Akira S; Komiya S; Nakamura T; Akiyama H; Imamura T
Mol Biol Cell; 2008 Dec; 19(12):5373-86. PubMed ID: 18843047
[TBL] [Abstract][Full Text] [Related]
18. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50.
Agrawal A; Cha-Molstad H; Samols D; Kushner I
J Immunol; 2001 Feb; 166(4):2378-84. PubMed ID: 11160296
[TBL] [Abstract][Full Text] [Related]
20. A role for caspases in controlling IL-4 expression in T cells.
Sehra S; Patel D; Kusam S; Wang ZY; Chang CH; Dent AL
J Immunol; 2005 Mar; 174(6):3440-6. PubMed ID: 15749878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
